Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6242
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence ; volume:21 ; number:10 ; day:27 ; month:7 ; year:2019 ; pages:1-8 ; date:10.2019
Current atherosclerosis reports ; 21, Heft 10 (27.7.2019), 1-8, 10.2019
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11883-019-0800-z
- URN
-
urn:nbn:de:101:1-2020012219383689752479
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Matthew M. Y.
- Sattar, Naveed
- McMurray, John J. V.
- Packard, Chris J.
- SpringerLink (Online service)
Other Objects (12)
Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care
Appetite and its Regulation: Are there Palatable Interventions for Heart Failure?
Vitamin D and COVID-19 infection and mortality in UK Biobank
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register
Excess risk of hospitalisation for heart failure among people with type 2 diabetes
The association of kidney function and cognitive decline in older patients at risk of cardiovascular disease: a longitudinal data analysis
Weight gain leads to greater adverse metabolic responses in South Asian compared with white European men: the GlasVEGAS study
Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care
Appetite and its Regulation: Are there Palatable Interventions for Heart Failure?
Vitamin D and COVID-19 infection and mortality in UK Biobank
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register
Excess risk of hospitalisation for heart failure among people with type 2 diabetes
The association of kidney function and cognitive decline in older patients at risk of cardiovascular disease: a longitudinal data analysis
Weight gain leads to greater adverse metabolic responses in South Asian compared with white European men: the GlasVEGAS study
Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care
Appetite and its Regulation: Are there Palatable Interventions for Heart Failure?
Vitamin D and COVID-19 infection and mortality in UK Biobank
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register
Excess risk of hospitalisation for heart failure among people with type 2 diabetes
The association of kidney function and cognitive decline in older patients at risk of cardiovascular disease: a longitudinal data analysis
Weight gain leads to greater adverse metabolic responses in South Asian compared with white European men: the GlasVEGAS study
Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease